Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1804 1
1950 1
1951 1
1953 1
1954 1
1956 3
1957 2
1958 2
1959 1
1960 1
1962 5
1963 2
1965 3
1966 2
1967 6
1968 7
1969 5
1970 1
1971 5
1972 8
1973 3
1974 5
1975 4
1976 3
1977 7
1978 2
1979 7
1980 4
1981 6
1982 10
1983 8
1984 14
1985 12
1986 13
1987 15
1988 7
1989 15
1990 9
1991 12
1992 13
1993 13
1994 9
1995 19
1996 8
1997 14
1998 12
1999 10
2000 12
2001 16
2002 14
2003 16
2004 12
2005 22
2006 22
2007 22
2008 23
2009 34
2010 23
2011 27
2012 32
2013 41
2014 25
2015 38
2016 37
2017 25
2018 30
2019 24
2020 32
2021 27
2022 39
2023 27
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

881 results

Results by year

Filters applied: . Clear all
Page 1
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia.
Daver N, Perl AE, Maly J, Levis M, Ritchie E, Litzow M, McCloskey J, Smith CC, Schiller G, Bradley T, Tiu RV, Naqvi K, Dail M, Brackman D, Siddani S, Wang J, Chyla B, Lee P, Altman JK. Daver N, et al. Among authors: bradley t. J Clin Oncol. 2022 Dec 10;40(35):4048-4059. doi: 10.1200/JCO.22.00602. Epub 2022 Jul 18. J Clin Oncol. 2022. PMID: 35849791 Free PMC article. Clinical Trial.
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Sallman DA, Al Malki MM, Asch AS, Wang ES, Jurcic JG, Bradley TJ, Flinn IW, Pollyea DA, Kambhampati S, Tanaka TN, Zeidner JF, Garcia-Manero G, Jeyakumar D, Komrokji R, Lancet J, Kantarjian HM, Gu L, Zhang Y, Tan A, Chao M, O'Hear C, Ramsingh G, Lal I, Vyas P, Daver NG. Sallman DA, et al. Among authors: bradley tj. J Clin Oncol. 2023 May 20;41(15):2815-2826. doi: 10.1200/JCO.22.01794. Epub 2023 Mar 8. J Clin Oncol. 2023. PMID: 36888930 Clinical Trial.
Single-Cell Transcriptomics of Mtb/HIV Co-Infection.
Kulkarni S, Endsley JJ, Lai Z, Bradley T, Sharan R. Kulkarni S, et al. Among authors: bradley t. Cells. 2023 Sep 17;12(18):2295. doi: 10.3390/cells12182295. Cells. 2023. PMID: 37759517 Free PMC article. Review.
Nucleoporins in cardiovascular disease.
Burdine RD, Preston CC, Leonard RJ, Bradley TA, Faustino RS. Burdine RD, et al. Among authors: bradley ta. J Mol Cell Cardiol. 2020 Apr;141:43-52. doi: 10.1016/j.yjmcc.2020.02.010. Epub 2020 Mar 21. J Mol Cell Cardiol. 2020. PMID: 32209327 Free PMC article. Review.
Net-zero emissions energy systems.
Davis SJ, Lewis NS, Shaner M, Aggarwal S, Arent D, Azevedo IL, Benson SM, Bradley T, Brouwer J, Chiang YM, Clack CTM, Cohen A, Doig S, Edmonds J, Fennell P, Field CB, Hannegan B, Hodge BM, Hoffert MI, Ingersoll E, Jaramillo P, Lackner KS, Mach KJ, Mastrandrea M, Ogden J, Peterson PF, Sanchez DL, Sperling D, Stagner J, Trancik JE, Yang CJ, Caldeira K. Davis SJ, et al. Among authors: bradley t. Science. 2018 Jun 29;360(6396):eaas9793. doi: 10.1126/science.aas9793. Science. 2018. PMID: 29954954 Free article. Review.
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Smith P, Bradley T, Gavarró LM, Goranova T, Ennis DP, Mirza HB, De Silva D, Piskorz AM, Sauer CM, Al-Khalidi S, Funingana IG, Reinius MAV, Giannone G, Lewsley LA, Stobo J, McQueen J, Bryson G, Eldridge M; BriTROC Investigators; Macintyre G, Markowetz F, Brenton JD, McNeish IA. Smith P, et al. Among authors: bradley t. Nat Commun. 2023 Jul 20;14(1):4387. doi: 10.1038/s41467-023-39867-7. Nat Commun. 2023. PMID: 37474499 Free PMC article.
Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.
Sauer CM, Hall JA, Couturier DL, Bradley T, Piskorz AM, Griffiths J, Sawle A, Eldridge MD, Smith P, Hosking K, Reinius MAV, Morrill Gavarró L, Mes-Masson AM, Ennis D, Millan D, Hoyle A, McNeish IA, Jimenez-Linan M, Martins FC, Tischer J, Vias M, Brenton JD. Sauer CM, et al. Among authors: bradley t. Nat Commun. 2023 Oct 16;14(1):6505. doi: 10.1038/s41467-023-41840-3. Nat Commun. 2023. PMID: 37845213 Free PMC article.
Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial.
Bradley TD, Logan AG, Lorenzi Filho G, Kimoff RJ, Durán Cantolla J, Arzt M, Redolfi S, Parati G, Kasai T, Dunlap ME, Delgado D, Yatsu S, Bertolami A, Pedrosa R, Tomlinson G, Marin Trigo JM, Tantucci C, Floras JS; ADVENT-HF Investigators. Bradley TD, et al. Lancet Respir Med. 2024 Feb;12(2):153-166. doi: 10.1016/S2213-2600(23)00374-0. Epub 2023 Dec 21. Lancet Respir Med. 2024. PMID: 38142697 Clinical Trial.
Servo-Ventilation Therapy for Sleep-Disordered Breathing.
Somers V, Arzt M, Bradley TD, Randerath W, Tamisier R, Won C. Somers V, et al. Among authors: bradley td. Chest. 2018 Jun;153(6):1501-1502. doi: 10.1016/j.chest.2018.03.052. Chest. 2018. PMID: 29884256 Review.
The SERVE-HF Trial.
Bradley TD, Floras JS; ADVENT-HF Investigators. Bradley TD, et al. Can Respir J. 2015 Nov-Dec;22(6):313. doi: 10.1155/2015/751615. Epub 2015 Oct 16. Can Respir J. 2015. PMID: 26474274 Free PMC article. No abstract available.
881 results